Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02380 encodes a long intergenic non-coding RNA transcript that does not overlap protein-coding genes and is presumed to regulate gene expression at different cellular levels, including transcription and chromatin remodeling. Dysregulation of lincRNAs such as LINC02380 is implicated in carcinogenesis and other diseases, with increasing interest in their utility as biomarkers and therapeutic targets. The specific biological function of LINC02380 remains to be fully elucidated, but evidence suggests altered expression in lung cancer, offering potential in tumor discrimination and diagnosis. Long intergenic non-coding RNAs typically demonstrate tissue- and development-specific expression patterns, participating in regulatory processes without encoding proteins.
For lncRNAs in general: modulation of gene expression, epigenetic regulation, interference with transcription factor activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2380 (LINC02380).